Related Experiment Videos
Transfusion for coagulopathy after heart surgery: efficacy of laboratory studies
Timothy S Hall1, Alan J Skoultchi
1Division of Cardiothoracic Surgery, University of California at San Francisco, San Francisco, California 94143-1267, USA. hallt@surgery.ucsf.edu
Insights
Identifying patients needing transfusions for coagulopathy after cardiac surgery is crucial. Pre- and postoperative coagulation tests, along with patient characteristics, help predict transfusion risk in these cardiac surgery patients.
Area of Science:
- Cardiology
- Transfusion Medicine
- Anesthesiology
Background:
- Coagulopathy following cardiac surgery necessitates transfusions, yet specific data and the utility of coagulation testing remain limited.
- Understanding risk factors and diagnostic markers is essential for optimizing transfusion strategies in cardiac surgical patients.
Purpose of the Study:
- To evaluate patient characteristics and pre- and postoperative coagulation test results associated with transfusion for coagulopathy after cardiac surgery.
- To identify predictors of transfusion requirements in the context of cardiac surgical procedures.
Main Methods:
- Retrospective review of 478 patients undergoing cardiac surgery (coronary bypass, valve, or combined procedures).
- Analysis of patient demographics, surgical variables, and pre- and postoperative coagulation test results (activated clotting time, partial thromboplastin time, antithrombin-III, prothrombin time, fibrinogen, fibrin split products).
- Comparison between patients who received transfusions for coagulopathy (n=101) and those who did not.
Main Results:
- Patients requiring transfusion were older, smaller, had more combined valve procedures, emergency operations, and preoperative heparin, with longer cardiopulmonary bypass times.
- Significant preoperative differences included activated clotting time, partial thromboplastin time, and antithrombin-III levels.
- Significant postoperative differences included prothrombin time, partial thromboplastin time, fibrinogen levels, and fibrin split products.
Conclusions:
- Patient characteristics and specific pre- and postoperative coagulation tests can effectively identify individuals at high risk for transfusion due to coagulopathy after cardiac surgery.
- These findings support the targeted use of coagulation monitoring and patient risk stratification to guide transfusion decisions in cardiac surgery.
Abstract:
Limited information exists regarding transfusions specifically for coagulopathy following cardiac surgery and the value of pre- and postoperative coagulation tests. Procedures (86% coronary bypass, 7.5% valve, and 6.5% combined valve and bypass) on 478 patients were reviewed; 101 patients (21%) were transfused for postoperative coagulopathy. Compared to those not transfused, patients with coagulopathy were significantly older and smaller, and they had more combined valve procedures, emergency operations, and preoperative heparin treatment as well as longer crossclamp and bypass times. Three preoperative tests showed significant differences in the coagulopathy group: activated clotting time, partial thromboplastin time, and antithrombin-III level. Four postoperative tests showed significant differences between the groups: prothrombin time, partial thromboplastin time, fibrinogen level, and fibrin split products at 10 dilutions. Patient characteristics and pre- and postoperative testing can identify patients at high risk of transfusion specifically related to coagulopathy.